Credent Connect N Care IPO Day 3: Issue subscribed 42.11x so far. Check issue details and key dates

3 min read     Updated on 17 Aug 2026, 12:25 PM
scanx
Reviewed by
Ritika DScanX News Team
AI Summary

Credent Connect N Care IPO closes with 42.11x subscription. QIB jumped 174% intraday to 17.80x. NII (sHNI) led with 60.51x. Allotment on Aug 18, Listing on Aug 20.

powered bylight_fuzz_icon
48491533

*this image is generated using AI for illustrative purposes only.

Credent Connect N Care’s IPO closed on Day 3 with a massive overall subscription of 42.11x, signaling overwhelming investor appetite for the healthcare logistics player. The issue saw robust participation across all categories, with Non-Institutional Investors (NII) leading the charge. The Qualified Institutional Buyer (QIB) segment surged dramatically, jumping from 6.49x to 17.80x in a single day. With the subscription window closed, the focus now shifts to allotment and listing.

Final Subscription Status

The IPO witnessed steady growth in subscriptions over the three-day window, culminating in a highly oversubscribed issue. The table below details the day-wise progression:

Day Date QIB NII (bHNI) NII (sHNI) Retail Total
Day 1 13-08-2026 1.00x 1.78x 1.43x 2.92x 2.08x
Day 2 14-08-2026 6.45x 12.20x 8.02x 15.42x 11.57x
Day 3 17-08-2026 17.80x 40.97x 60.51x 50.96x 42.11x

Intra-day timeline on 17-08-2026

Time (IST) QIB NII (bHNI) Retail Total
05:45 6.49x 29.51x 37.05x 27.48x
06:45 17.80x 40.97x 50.96x 42.11x

The momentum was particularly strong in the final hours, with the total subscription ticking up by 53.2% from the morning snapshot. QIB investors doubled their interest, jumping +174.3% today (from 6.49x to 17.80x), while NII (bHNI) and Retail also saw significant jumps of +38.8% and +37.5% respectively.

Category-wise Breakdown

  • NII (sHNI): Led the subscription with 60.51x, indicating strong interest from small high-net-worth individuals.
  • NII (bHNI): Booked 40.97x, showing significant demand from big high-net-worth individuals.
  • Retail: Subscribed at 50.96x, reflecting strong retail participation.
  • QIB: Institutional investors subscribed at 17.80x after a sharp intraday rise.

About the Company

Credent Connect N Care is a healthcare services provider engaged in delivering integrated logistics, workforce solutions, and technology-enabled support to healthcare institutions across India. Founded in 2015, the company provides comprehensive operational and logistics services to diagnostic laboratories, In Vitro Diagnostics (IVD) companies, pharmaceutical companies, clinics, and other healthcare enterprises. Its offerings include home sample collection through trained phlebotomists, Operations & Supply Chain Services, deployment of skilled laboratory technicians, and specialized inter-state and intra-state logistics services. As of June 30, 2026, the company employed 2589 riders. The management team includes MD Tarun Sharma and CFO Karan Sharma.

Financial Highlights

The company has shown significant revenue growth over the past two years. Below are the consolidated financial highlights for the last three fiscal years:

Particulars FY 2024 (₹ crores) FY 2025 (₹ crores) FY 2026 (₹ crores)
Revenue from Operations 75.73 77.94 214.16
Total Profit 2.66 2.25 18.45
Total Equity 13.66 15.90 43.79

Revenue from operations surged to ₹214.16 crores in FY 2026 from ₹77.94 crores in FY 2025. Total profit also jumped significantly to ₹18.45 crores in FY 2026 compared to ₹2.25 crores in FY 2025.

Objects of the Issue

The proceeds from the IPO will be utilized for the following purposes:

  • Investment in wholly owned subsidiary for working capital requirement: ₹26.80 crores to meet working capital requirements for trade receivables and day-to-day operations.
  • Investment in wholly owned subsidiary for capital expenditure requirements for machinery: ₹3.00 crores for procuring sonography and digital X-ray machines.
  • To meet Working Capital Requirements: ₹37.00 crores for long-term working capital needs including inventory and debtors.
  • Repayment and/or prepayment of borrowings: ₹6.00 crores to reduce outstanding indebtedness.
  • General corporate purposes: For operating expenses, marketing, and business development.

Risk Factors

  • High Customer Concentration Risk: The company derives 81.76% of revenue from its top 10 customers without firm commitments; loss of major clients could impact performance.
  • Dependence on Healthcare Industry Volumes: Business is dependent on diagnostic testing volumes and outsourcing requirements; any reduction could affect operations.
  • Sample Transportation and Contamination Risk: Exposure to risks of loss, damage, or contamination during transportation could lead to client claims and reputational harm.

What's Next

  • Allotment Date: 2026-08-18
  • Listing Date: 2026-08-20
  • Basis of Allotment: Pro-rata basis is expected given the high subscription levels, subject to SEBI guidelines.

How might the high customer concentration risk (81.76% from top 10 clients) impact Credent Connect N Care's revenue stability post-listing?

Will the pro-rata allotment process significantly dampen retail investor enthusiasm for the listing day compared to the subscription phase?

How does the sharp increase in FY 2026 profitability compare to industry peers, and is this growth sustainable given the reliance on diagnostic volumes?

like20
dislike

Credent Connect N Care IPO Day 2 Live: Total hits 11.57x; Retail leads at 15.42x - Check analysts view and more

4 min read     Updated on 17 Aug 2026, 12:25 PM
scanx
Reviewed by
Ritika DScanX News Team
AI Summary

Credent Connect N Care IPO subscription reached 11.57x on Day 2, with Retail leading at 15.42x and bHNI at 12.20x. The healthcare logistics firm reported FY26 revenue of ₹214.16 crores. Key risks include customer concentration and sample transport issues. The IPO closes on August 17, 2026.

powered bylight_fuzz_icon
48232383

*this image is generated using AI for illustrative purposes only.

Credent Connect N Care’s IPO closed on Day 3 with a massive overall subscription of 42.11x, signaling overwhelming investor appetite for the healthcare logistics player. The issue saw robust participation across all categories, with Non-Institutional Investors (NII) leading the charge. The Qualified Institutional Buyer (QIB) segment surged dramatically, jumping from 6.49x to 17.80x in a single day. With the subscription window closed, the focus now shifts to allotment and listing.

Final Subscription Status

The IPO witnessed steady growth in subscriptions over the three-day window, culminating in a highly oversubscribed issue. The table below details the day-wise progression:

Day Date QIB NII (bHNI) NII (sHNI) Retail Total
Day 1 13-08-2026 1.00x 1.78x 1.43x 2.92x 2.08x
Day 2 14-08-2026 6.45x 12.20x 8.02x 15.42x 11.57x
Day 3 17-08-2026 17.80x 40.97x 60.51x 50.96x 42.11x

Intra-day timeline on 17-08-2026

Time (IST) QIB NII (bHNI) Retail Total
05:45 6.49x 29.51x 37.05x 27.48x
06:45 17.80x 40.97x 50.96x 42.11x

The momentum was particularly strong in the final hours, with the total subscription ticking up by 53.2% from the morning snapshot. QIB investors doubled their interest, jumping +174.3% today (from 6.49x to 17.80x), while NII (bHNI) and Retail also saw significant jumps of +38.8% and +37.5% respectively.

Category-wise Breakdown

  • NII (sHNI): Led the subscription with 60.51x, indicating strong interest from small high-net-worth individuals.
  • NII (bHNI): Booked 40.97x, showing significant demand from big high-net-worth individuals.
  • Retail: Subscribed at 50.96x, reflecting strong retail participation.
  • QIB: Institutional investors subscribed at 17.80x after a sharp intraday rise.

About the Company

Credent Connect N Care is a healthcare services provider engaged in delivering integrated logistics, workforce solutions, and technology-enabled support to healthcare institutions across India. Founded in 2015, the company provides comprehensive operational and logistics services to diagnostic laboratories, In Vitro Diagnostics (IVD) companies, pharmaceutical companies, clinics, and other healthcare enterprises. Its offerings include home sample collection through trained phlebotomists, Operations & Supply Chain Services, deployment of skilled laboratory technicians, and specialized inter-state and intra-state logistics services. As of June 30, 2026, the company employed 2589 riders. The management team includes MD Tarun Sharma and CFO Karan Sharma.

Financial Highlights

The company has shown significant revenue growth over the past two years. Below are the consolidated financial highlights for the last three fiscal years:

Particulars FY 2024 (₹ crores) FY 2025 (₹ crores) FY 2026 (₹ crores)
Revenue from Operations 75.73 77.94 214.16
Total Profit 2.66 2.25 18.45
Total Equity 13.66 15.90 43.79

Revenue from operations surged to ₹214.16 crores in FY 2026 from ₹77.94 crores in FY 2025. Total profit also jumped significantly to ₹18.45 crores in FY 2026 compared to ₹2.25 crores in FY 2025.

Objects of the Issue

The proceeds from the IPO will be utilized for the following purposes:

  • Investment in wholly owned subsidiary for working capital requirement: ₹26.80 crores to meet working capital requirements for trade receivables and day-to-day operations.
  • Investment in wholly owned subsidiary for capital expenditure requirements for machinery: ₹3.00 crores for procuring sonography and digital X-ray machines.
  • To meet Working Capital Requirements: ₹37.00 crores for long-term working capital needs including inventory and debtors.
  • Repayment and/or prepayment of borrowings: ₹6.00 crores to reduce outstanding indebtedness.
  • General corporate purposes: For operating expenses, marketing, and business development.

Risk Factors

  • High Customer Concentration Risk: The company derives 81.76% of revenue from its top 10 customers without firm commitments; loss of major clients could impact performance.
  • Dependence on Healthcare Industry Volumes: Business is dependent on diagnostic testing volumes and outsourcing requirements; any reduction could affect operations.
  • Sample Transportation and Contamination Risk: Exposure to risks of loss, damage, or contamination during transportation could lead to client claims and reputational harm.

What's Next

  • Allotment Date: 2026-08-18
  • Listing Date: 2026-08-20
  • Basis of Allotment: Pro-rata basis is expected given the high subscription levels, subject to SEBI guidelines.

Given the 81.76% revenue concentration from the top 10 customers, how might post-listing volatility impact Credent Connect N Care's ability to retain these key healthcare partners?

With FY 2026 profits surging to ₹18.45 crores from ₹2.25 crores, what specific operational efficiencies or market expansions drove this disproportionate growth compared to revenue?

How will the allocation of ₹37.00 crores for long-term working capital affect the company's cash flow dynamics and debt levels in the immediate post-IPO period?

like19
dislike

Credent Connect N Care IPO

IPO Open Now
Price Range ₹ 179 – ₹ 189
Min Investment₹ 2,14,800
Issue Size₹ 93.90 Cr.
Lot Size600
Date13 Aug - 17 Aug
View IPO Details arrow